Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has earned an average rating of “Moderate Buy” from the four research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation and three have given a buy recommendation to the company. The average 12 month price […]

Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a […]

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on the […]

Elicio Therapeutics, Inc. (NASDAQ:ELTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating […]

Aehr Test Systems (NASDAQ:AEHR – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, five have assigned a buy recommendation and one has […]

MGIC Investment Corporation (NYSE:MTG – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and two have given a strong buy recommendation to […]

Avnet, Inc. (NASDAQ:AVT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, two have assigned a buy rating and two have […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven ratings firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, eight have given a buy recommendation and […]

Shares of NWPX Infrastructure, Inc. (NASDAQ:NWPX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a […]

Enovix Corporation (NASDAQ:ENVX – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twelve ratings firms that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, six have given a buy recommendation and […]

Shares of Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eight ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have given a buy […]

Shares of Intermediate Capital Group plc (LON:ICG – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. […]

Shares of DoorDash, Inc. (NASDAQ:DASH – Get Free Report) have earned an average rating of “Moderate Buy” from the thirty-six research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, twenty-six have assigned a buy rating and one has issued […]

Allegro MicroSystems, Inc. (NASDAQ:ALGM – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twelve analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, nine have assigned a buy recommendation and one has […]

Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the fifteen research firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have given a buy recommendation […]

Shares of Keurig Dr Pepper, Inc (NASDAQ:KDP – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the nineteen brokerages that are currently covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 […]

Jernigan Capital, Inc. (NASDAQ:JCAP – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one […]

Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have earned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating […]

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 […]

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, four have assigned a buy recommendation and one has issued […]